Industry Research Reports
Home > Reports > Chemical & Material > Isoprinosine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Isoprinosine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Chemical & Material
Published Date: 2024-01-18
Pages: 123 Pages
Report ld: 2213652
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Isoprinosine Market Size(US$)
CAGR 2024-2030
3.8%
Market Size,2030
USD 301.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 241 million
Market Forecast in 2030(Value)
US$ 301.4 million
CAGR
3.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Isoprinosine has been used in SSPE, herpes simplex virus, human papillomavirus, HIV, influenza virus, and airway virus infections, cytomegalovirus, and Epstein-Barr virus infections.
In our report, for the tablet, one unit is 20 tablets in one box. For the syrup, one unit is one bottle.
The global market for Isoprinosine was estimated to be worth US$ 232 million in 2023 and is forecast to a readjusted size of US$ 301.4 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030
Global key players of Isoprinosine include Newport Pharmaceuticals, Gedeon Richter, Sanofi, etc. The top three players hold a share over 60%.
Europe is the largest market, has a share about 63%, followed by Middle East, Africa and Latin America, with share18%.
In terms of product type, tablet is the largest segment, occupied for a share of 91%, and in terms of application, pharmacy has a share about 51 percent.
MARKET SEGMENTATION
By Company
- Newport Pharmaceuticals
- Gedeon Richter
- Mochida
- Sanofi
- Andrómaco
- Yung Shin
- Alfasigma SpA
- Polfarmex
- Sanfer
- Meprofarm
- Novell Pharmaceutical
- Aflofarm
- KoRa Healthcare
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Tablet
- Syrup
Segment by Application
- Hospital & Clinic
- Pharmacy
- Other
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Isoprinosine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Isoprinosine by region & country, by Type, and by Application.
The Isoprinosine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoprinosine.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Isoprinosine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Isoprinosine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Isoprinosine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Isoprinosine Product Introduction
1.2 Global Isoprinosine Market Size Forecast
1.2.1 Global Isoprinosine Sales Value (2019-2030)
1.2.2 Global Isoprinosine Sales Volume (2019-2030)
1.2.3 Global Isoprinosine Sales Price (2019-2030)
1.3 Isoprinosine Market Trends & Drivers
1.3.1 Isoprinosine Industry Trends
1.3.2 Isoprinosine Market Drivers & Opportunity
1.3.3 Isoprinosine Market Challenges
1.3.4 Isoprinosine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Isoprinosine Players Revenue Ranking (2023)
2.2 Global Isoprinosine Revenue by Company (2019-2024)
2.3 Global Isoprinosine Players Sales Volume Ranking (2023)
2.4 Global Isoprinosine Sales Volume by Company Players (2019-2024)
2.5 Global Isoprinosine Average Price by Company (2019-2024)
2.6 Key Manufacturers Isoprinosine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Isoprinosine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Isoprinosine
2.9 Isoprinosine Market Competitive Analysis
2.9.1 Isoprinosine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Isoprinosine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoprinosine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Syrup
3.2 Global Isoprinosine Sales Value by Type
3.2.1 Global Isoprinosine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Isoprinosine Sales Value, by Type (2019-2030)
3.2.3 Global Isoprinosine Sales Value, by Type (%) (2019-2030)
3.3 Global Isoprinosine Sales Volume by Type
3.3.1 Global Isoprinosine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Isoprinosine Sales Volume, by Type (2019-2030)
3.3.3 Global Isoprinosine Sales Volume, by Type (%) (2019-2030)
3.4 Global Isoprinosine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital & Clinic
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Isoprinosine Sales Value by Application
4.2.1 Global Isoprinosine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Isoprinosine Sales Value, by Application (2019-2030)
4.2.3 Global Isoprinosine Sales Value, by Application (%) (2019-2030)
4.3 Global Isoprinosine Sales Volume by Application
4.3.1 Global Isoprinosine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Isoprinosine Sales Volume, by Application (2019-2030)
4.3.3 Global Isoprinosine Sales Volume, by Application (%) (2019-2030)
4.4 Global Isoprinosine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Isoprinosine Sales Value by Region
5.1.1 Global Isoprinosine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Isoprinosine Sales Value by Region (2019-2024)
5.1.3 Global Isoprinosine Sales Value by Region (2025-2030)
5.1.4 Global Isoprinosine Sales Value by Region (%), (2019-2030)
5.2 Global Isoprinosine Sales Volume by Region
5.2.1 Global Isoprinosine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Isoprinosine Sales Volume by Region (2019-2024)
5.2.3 Global Isoprinosine Sales Volume by Region (2025-2030)
5.2.4 Global Isoprinosine Sales Volume by Region (%), (2019-2030)
5.3 Global Isoprinosine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Isoprinosine Sales Value, 2019-2030
5.4.2 North America Isoprinosine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Isoprinosine Sales Value, 2019-2030
5.5.2 Europe Isoprinosine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Isoprinosine Sales Value, 2019-2030
5.6.2 Asia Pacific Isoprinosine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Isoprinosine Sales Value, 2019-2030
5.7.2 South America Isoprinosine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Isoprinosine Sales Value, 2019-2030
5.8.2 Middle East & Africa Isoprinosine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Isoprinosine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Isoprinosine Sales Value
6.2.1 Key Countries/Regions Isoprinosine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Isoprinosine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Isoprinosine Sales Value, 2019-2030
6.3.2 United States Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Isoprinosine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Isoprinosine Sales Value, 2019-2030
6.4.2 Europe Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Isoprinosine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Isoprinosine Sales Value, 2019-2030
6.5.2 China Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Isoprinosine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Isoprinosine Sales Value, 2019-2030
6.6.2 Japan Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Isoprinosine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Isoprinosine Sales Value, 2019-2030
6.7.2 South Korea Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Isoprinosine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Isoprinosine Sales Value, 2019-2030
6.8.2 Southeast Asia Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Isoprinosine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Isoprinosine Sales Value, 2019-2030
6.9.2 India Isoprinosine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Isoprinosine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Newport Pharmaceuticals
7.1.1 Newport Pharmaceuticals Company Information
7.1.2 Newport Pharmaceuticals Introduction and Business Overview
7.1.3 Newport Pharmaceuticals Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Newport Pharmaceuticals Isoprinosine Product Offerings
7.1.5 Newport Pharmaceuticals Recent Development
7.2 Gedeon Richter
7.2.1 Gedeon Richter Company Information
7.2.2 Gedeon Richter Introduction and Business Overview
7.2.3 Gedeon Richter Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Gedeon Richter Isoprinosine Product Offerings
7.2.5 Gedeon Richter Recent Development
7.3 Mochida
7.3.1 Mochida Company Information
7.3.2 Mochida Introduction and Business Overview
7.3.3 Mochida Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Mochida Isoprinosine Product Offerings
7.3.5 Mochida Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Information
7.4.2 Sanofi Introduction and Business Overview
7.4.3 Sanofi Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Isoprinosine Product Offerings
7.4.5 Sanofi Recent Development
7.5 Andrómaco
7.5.1 Andrómaco Company Information
7.5.2 Andrómaco Introduction and Business Overview
7.5.3 Andrómaco Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Andrómaco Isoprinosine Product Offerings
7.5.5 Andrómaco Recent Development
7.6 Yung Shin
7.6.1 Yung Shin Company Information
7.6.2 Yung Shin Introduction and Business Overview
7.6.3 Yung Shin Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Yung Shin Isoprinosine Product Offerings
7.6.5 Yung Shin Recent Development
7.7 Alfasigma SpA
7.7.1 Alfasigma SpA Company Information
7.7.2 Alfasigma SpA Introduction and Business Overview
7.7.3 Alfasigma SpA Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Alfasigma SpA Isoprinosine Product Offerings
7.7.5 Alfasigma SpA Recent Development
7.8 Polfarmex
7.8.1 Polfarmex Company Information
7.8.2 Polfarmex Introduction and Business Overview
7.8.3 Polfarmex Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Polfarmex Isoprinosine Product Offerings
7.8.5 Polfarmex Recent Development
7.9 Sanfer
7.9.1 Sanfer Company Information
7.9.2 Sanfer Introduction and Business Overview
7.9.3 Sanfer Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Sanfer Isoprinosine Product Offerings
7.9.5 Sanfer Recent Development
7.10 Meprofarm
7.10.1 Meprofarm Company Information
7.10.2 Meprofarm Introduction and Business Overview
7.10.3 Meprofarm Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Meprofarm Isoprinosine Product Offerings
7.10.5 Meprofarm Recent Development
7.11 Novell Pharmaceutical
7.11.1 Novell Pharmaceutical Company Information
7.11.2 Novell Pharmaceutical Introduction and Business Overview
7.11.3 Novell Pharmaceutical Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Novell Pharmaceutical Isoprinosine Product Offerings
7.11.5 Novell Pharmaceutical Recent Development
7.12 Aflofarm
7.12.1 Aflofarm Company Information
7.12.2 Aflofarm Introduction and Business Overview
7.12.3 Aflofarm Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Aflofarm Isoprinosine Product Offerings
7.12.5 Aflofarm Recent Development
7.13 KoRa Healthcare
7.13.1 KoRa Healthcare Company Information
7.13.2 KoRa Healthcare Introduction and Business Overview
7.13.3 KoRa Healthcare Isoprinosine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 KoRa Healthcare Isoprinosine Product Offerings
7.13.5 KoRa Healthcare Recent Development
8 Industry Chain Analysis
8.1 Isoprinosine Industrial Chain
8.2 Isoprinosine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Isoprinosine Sales Model
8.5.2 Sales Channel
8.5.3 Isoprinosine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Isoprinosine Market Trends
Table 2. Isoprinosine Market Drivers & Opportunity
Table 3. Isoprinosine Market Challenges
Table 4. Isoprinosine Market Restraints
Table 5. Global Isoprinosine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Isoprinosine Revenue Market Share by Company (2019-2024)
Table 7. Global Isoprinosine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Isoprinosine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Isoprinosine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Isoprinosine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Isoprinosine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Isoprinosine
Table 13. Global Isoprinosine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoprinosine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Isoprinosine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Isoprinosine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Isoprinosine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Isoprinosine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Isoprinosine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Isoprinosine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Isoprinosine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Isoprinosine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Isoprinosine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Isoprinosine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Isoprinosine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Isoprinosine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Isoprinosine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Isoprinosine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Isoprinosine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Isoprinosine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Isoprinosine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Isoprinosine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Isoprinosine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Isoprinosine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Isoprinosine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Isoprinosine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Isoprinosine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Isoprinosine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Isoprinosine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Isoprinosine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Isoprinosine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Isoprinosine Sales Value by Region (2019-2024) & (%)
Table 44. Global Isoprinosine Sales Value by Region (2025-2030) & (%)
Table 45. Global Isoprinosine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Isoprinosine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Isoprinosine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Isoprinosine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Isoprinosine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Isoprinosine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Isoprinosine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Isoprinosine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Isoprinosine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Isoprinosine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Isoprinosine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Isoprinosine Sales Volume, (2025-2030) & (K Units)
Table 57. Newport Pharmaceuticals Company Information
Table 58. Newport Pharmaceuticals Introduction and Business Overview
Table 59. Newport Pharmaceuticals Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Newport Pharmaceuticals Isoprinosine Product Offerings
Table 61. Newport Pharmaceuticals Recent Development
Table 62. Gedeon Richter Company Information
Table 63. Gedeon Richter Introduction and Business Overview
Table 64. Gedeon Richter Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Gedeon Richter Isoprinosine Product Offerings
Table 66. Gedeon Richter Recent Development
Table 67. Mochida Company Information
Table 68. Mochida Introduction and Business Overview
Table 69. Mochida Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Mochida Isoprinosine Product Offerings
Table 71. Mochida Recent Development
Table 72. Sanofi Company Information
Table 73. Sanofi Introduction and Business Overview
Table 74. Sanofi Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Sanofi Isoprinosine Product Offerings
Table 76. Sanofi Recent Development
Table 77. Andrómaco Company Information
Table 78. Andrómaco Introduction and Business Overview
Table 79. Andrómaco Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Andrómaco Isoprinosine Product Offerings
Table 81. Andrómaco Recent Development
Table 82. Yung Shin Company Information
Table 83. Yung Shin Introduction and Business Overview
Table 84. Yung Shin Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Yung Shin Isoprinosine Product Offerings
Table 86. Yung Shin Recent Development
Table 87. Alfasigma SpA Company Information
Table 88. Alfasigma SpA Introduction and Business Overview
Table 89. Alfasigma SpA Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Alfasigma SpA Isoprinosine Product Offerings
Table 91. Alfasigma SpA Recent Development
Table 92. Polfarmex Company Information
Table 93. Polfarmex Introduction and Business Overview
Table 94. Polfarmex Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Polfarmex Isoprinosine Product Offerings
Table 96. Polfarmex Recent Development
Table 97. Sanfer Company Information
Table 98. Sanfer Introduction and Business Overview
Table 99. Sanfer Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Sanfer Isoprinosine Product Offerings
Table 101. Sanfer Recent Development
Table 102. Meprofarm Company Information
Table 103. Meprofarm Introduction and Business Overview
Table 104. Meprofarm Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Meprofarm Isoprinosine Product Offerings
Table 106. Meprofarm Recent Development
Table 107. Novell Pharmaceutical Company Information
Table 108. Novell Pharmaceutical Introduction and Business Overview
Table 109. Novell Pharmaceutical Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Novell Pharmaceutical Isoprinosine Product Offerings
Table 111. Novell Pharmaceutical Recent Development
Table 112. Aflofarm Company Information
Table 113. Aflofarm Introduction and Business Overview
Table 114. Aflofarm Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Aflofarm Isoprinosine Product Offerings
Table 116. Aflofarm Recent Development
Table 117. KoRa Healthcare Company Information
Table 118. KoRa Healthcare Introduction and Business Overview
Table 119. KoRa Healthcare Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. KoRa Healthcare Isoprinosine Product Offerings
Table 121. KoRa Healthcare Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Isoprinosine Downstream Customers
Table 125. Isoprinosine Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Isoprinosine Product Picture
Figure 2. Global Isoprinosine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Isoprinosine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Isoprinosine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Isoprinosine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Isoprinosine Report Years Considered
Figure 7. Global Isoprinosine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Isoprinosine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Isoprinosine Revenue in 2023
Figure 10. Isoprinosine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Tablet Picture
Figure 12. Syrup Picture
Figure 13. Global Isoprinosine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Isoprinosine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Isoprinosine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Isoprinosine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Isoprinosine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital & Clinic
Figure 19. Product Picture of Pharmacy
Figure 20. Product Picture of Other
Figure 21. Global Isoprinosine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Isoprinosine Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Isoprinosine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Isoprinosine Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Isoprinosine Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Isoprinosine Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Isoprinosine Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Isoprinosine Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Isoprinosine Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Isoprinosine Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Isoprinosine Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Isoprinosine Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Isoprinosine Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Isoprinosine Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Isoprinosine Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Isoprinosine Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Isoprinosine Sales Volume (%), (2019-2030)
Figure 38. United States Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 44. China Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 46. China Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 56. India Isoprinosine Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Isoprinosine Sales Value by Type (%), 2023 VS 2030
Figure 58. India Isoprinosine Sales Value by Application (%), 2023 VS 2030
Figure 59. Isoprinosine Industrial Chain
Figure 60. Isoprinosine Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Isoprinosine in 2030?
The global market size of Isoprinosine in 2030 was 301.4 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Isoprinosine in 2024?
Which companies rank high in the global Isoprinosine market?
What is the annual compound growth rate of the global Isoprinosine market size from 2024 to 2030?
Related Reports
Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Isoprinosine market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 336 million by 2032 with a CAGR of 3.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 98
USD 4250.00
(Single User License)
Global Isoprinosine Market Research Report 2026
The global Isoprinosine market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 336 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 138
USD 2900.00
(Single User License)
Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Isoprinosine was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 336 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Isoprinosine market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 99
USD 4250.00
(Single User License)
Global Isoprinosine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Isoprinosine market is projected to grow from US$ 249 million in 2024 to US$ 322 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 166
USD 4900.00
(Single User License)
Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Isoprinosine was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 126
USD 3950.00
(Single User License)
Global Isoprinosine Market Research Report 2025
The global market for Isoprinosine was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 322 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-01-19
Pages: 104
USD 2900.00
(Single User License)
Global Isoprinosine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-04-17
Pages: 162
USD 5600.00
(Single User License)
Global Isoprinosine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-04-16
Pages: 150
USD 5900.00
(Single User License)
Global Isoprinosine Market Insights, Forecast to 2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-04-07
Pages: 113
USD 4900.00
(Single User License)
Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Isoprinosine market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 336 million by 2032 with a CAGR of 3.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 98
USD 4250.00 (Single User License)Global Isoprinosine Market Research Report 2026
The global Isoprinosine market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 336 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 138
USD 2900.00 (Single User License)Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Isoprinosine was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 336 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 3950.00 (Single User License)Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Isoprinosine market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 99
USD 4250.00 (Single User License)Global Isoprinosine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Isoprinosine market is projected to grow from US$ 249 million in 2024 to US$ 322 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 166
USD 4900.00 (Single User License)Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Isoprinosine was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 126
USD 3950.00 (Single User License)Global Isoprinosine Market Research Report 2025
The global market for Isoprinosine was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 322 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-01-19
Pages: 104
USD 2900.00 (Single User License)Global Isoprinosine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-04-17
Pages: 162
USD 5600.00 (Single User License)Global Isoprinosine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-04-16
Pages: 150
USD 5900.00 (Single User License)Global Isoprinosine Market Insights, Forecast to 2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-04-07
Pages: 113
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now